199 related articles for article (PubMed ID: 29732996)
1. Targeting Trypanothione Reductase of Leishmanial major to Fight Against Cutaneous Leishmaniasis.
Dukhyil AAAB
Infect Disord Drug Targets; 2019; 19(4):388-393. PubMed ID: 29732996
[TBL] [Abstract][Full Text] [Related]
2. Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism.
Colotti G; Saccoliti F; Gramiccia M; Di Muccio T; Prakash J; Yadav S; Dubey VK; Vistoli G; Battista T; Mocci S; Fiorillo A; Bibi A; Madia VN; Messore A; Costi R; Di Santo R; Ilari A
Amino Acids; 2020 Feb; 52(2):247-259. PubMed ID: 31037461
[TBL] [Abstract][Full Text] [Related]
3. Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening.
Turcano L; Torrente E; Missineo A; Andreini M; Gramiccia M; Di Muccio T; Genovese I; Fiorillo A; Harper S; Bresciani A; Colotti G; Ilari A
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006969. PubMed ID: 30475811
[TBL] [Abstract][Full Text] [Related]
4. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential anti-leishmanial agents using computational investigation and biological evaluation against trypanothione reductase.
Kuldeep J; R K; Kaur P; Goyal N; Siddiqi MI
J Biomol Struct Dyn; 2021 Feb; 39(3):960-969. PubMed ID: 31984862
[TBL] [Abstract][Full Text] [Related]
6. Development of Thiophene Compounds as Potent Chemotherapies for the Treatment of Cutaneous Leishmaniasis Caused by
Rodriguez F; Iniguez E; Pena Contreras G; Ahmed H; Costa TEMM; Skouta R; Maldonado RA
Molecules; 2018 Jul; 23(7):. PubMed ID: 29973498
[No Abstract] [Full Text] [Related]
7. Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach.
Pandey RK; Sharma D; Bhatt TK; Sundar S; Prajapati VK
J Biomol Struct Dyn; 2015; 33(12):2541-53. PubMed ID: 26305585
[TBL] [Abstract][Full Text] [Related]
8. Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation.
Pandey RK; Kumbhar BV; Srivastava S; Malik R; Sundar S; Kunwar A; Prajapati VK
J Biomol Struct Dyn; 2017 Jan; 35(1):141-158. PubMed ID: 27043972
[TBL] [Abstract][Full Text] [Related]
9. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
[TBL] [Abstract][Full Text] [Related]
10. Screening of Novel Inhibitors Against Leishmania donovani Calcium ion Channel to Fight Leishmaniasis.
Kashif M; Manna PP; Akhter Y; Alaidarous M; Rub A
Infect Disord Drug Targets; 2017; 17(2):120-129. PubMed ID: 28034363
[TBL] [Abstract][Full Text] [Related]
11. Beyond traditional medications: exploring novel and potential inhibitors of trypanothione reductase (LmTr) of Leishmania parasites.
Sarfraz M; Bakht MA; Alshammari MS; Alrofaidi M; Alzahrani AR; Eltaib L; Asdaq SMB; Aba Alkhayl FF; Abida ; Mohd Imran
J Biomol Struct Dyn; 2024 Jan; ():1-14. PubMed ID: 38213287
[TBL] [Abstract][Full Text] [Related]
12. Antileishmanial activity and trypanothione reductase effects of terpenes from the Amazonian species Croton cajucara Benth (Euphorbiaceae).
Lima GS; Castro-Pinto DB; Machado GC; Maciel MA; Echevarria A
Phytomedicine; 2015 Nov; 22(12):1133-7. PubMed ID: 26547537
[TBL] [Abstract][Full Text] [Related]
13. Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases.
Battista T; Colotti G; Ilari A; Fiorillo A
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326257
[TBL] [Abstract][Full Text] [Related]
14. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
[TBL] [Abstract][Full Text] [Related]
15. Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials.
Cunningham ML; Fairlamb AH
Eur J Biochem; 1995 Jun; 230(2):460-8. PubMed ID: 7607216
[TBL] [Abstract][Full Text] [Related]
16. Screening natural products database for identification of potential antileishmanial chemotherapeutic agents.
Venkatesan SK; Saudagar P; Shukla AK; Dubey VK
Interdiscip Sci; 2011 Sep; 3(3):217-31. PubMed ID: 21956744
[TBL] [Abstract][Full Text] [Related]
17. Insights about resveratrol analogs against trypanothione reductase of
da Silva AD; Dos Santos JA; Machado PA; Alves LA; Laque LC; de Souza VC; Coimbra ES; Capriles PVSZ
J Biomol Struct Dyn; 2019 Jul; 37(11):2960-2969. PubMed ID: 30058445
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives.
Saccoliti F; Angiulli G; Pupo G; Pescatori L; Madia VN; Messore A; Colotti G; Fiorillo A; Scipione L; Gramiccia M; Di Muccio T; Di Santo R; Costi R; Ilari A
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):304-310. PubMed ID: 28098499
[TBL] [Abstract][Full Text] [Related]
19. Thiol redox biology of trypanosomatids and potential targets for chemotherapy.
Leroux AE; Krauth-Siegel RL
Mol Biochem Parasitol; 2016; 206(1-2):67-74. PubMed ID: 26592324
[TBL] [Abstract][Full Text] [Related]
20. Toward a Drug Against All Kinetoplastids: From LeishBox to Specific and Potent Trypanothione Reductase Inhibitors.
Ilari A; Genovese I; Fiorillo F; Battista T; De Ionna I; Fiorillo A; Colotti G
Mol Pharm; 2018 Aug; 15(8):3069-3078. PubMed ID: 29897765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
